Vietnam Periodontal Therapeutics Market Analysis

Vietnam Periodontal Therapeutics Market Executive Summary

Vietnam Periodontal Therapeutics Market is at around $4.4 Mn in 2023 and is projected to reach $7.2 Mn in 2030, exhibiting a CAGR of 7.43% during the forecast period.

Gum inflammation and infection are common symptoms of periodontal disease, also referred to as gum disease, which is a serious dental condition. The use of therapeutic, non-surgical, or surgical treatment techniques can help prevent periodontitis, a prevalent ailment frequently brought on by poor dental hygiene. Periodontal therapy, which is the exclusive use of antibiotics to treat periodontitis, is a relatively new yet effective therapeutic approach that is gaining popularity among patients and dental professionals. Periodontal therapy frequently uses antibiotics such as metronidazole, doxycycline, and amoxicillin. The use of mouthwashes and rinses containing antimicrobials such hydrogen peroxide, chlorhexidine, and essential oils as adjuvant therapy can lessen plaque and gingival irritation.

In Vietnam, periodontal disease affects about 50-60% of the population, predominantly adults. Key demographic factors include urbanization, with higher prevalence in urban areas due to lifestyle and dietary habits. The market is influenced by a younger demographic becoming increasingly aware of oral health. Healthcare expenses for periodontal treatments are on the rise, driven by greater demand for dental services and improvements in healthcare infrastructure. Despite economic challenges, government initiatives and private sector investments are contributing to the growth of the periodontal market, aiming to enhance the quality and accessibility of dental care. Therefore, the market is driven by significant factors like Rising Awareness About Dental Hygiene, Economic Growth and Rising Disposable Income, and Advancements in Treatment Technologies. However, Adverse Effects, Limited insurance coverage for periodontal treatments, and High Costs restrict the growth and potential of the market.

Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel complement therapeutics, announced positive top-line Phase 2 results from its randomized, placebo-controlled clinical trial.

Market Dynamics

Market Growth Drivers

Rising Awareness About Dental Hygiene: Promoting awareness of the connection between oral and general health, governments and health groups are leading educational programs. Preventive dentistry care and periodontal therapies are in more demand as a result of this. Surveys indicate a 35% increase in consumer demand for dental hygiene products and professional periodontal treatments following educational campaigns. Innovative methods for treatment and prevention are offered by the market in response to this growing consumer interest and awareness.

Economic Growth and Rising Disposable Income: Increased disposable income has expanded the consumer base for advanced dental treatments in Vietnam. Market dynamics are shifting as more individuals can afford and choose high-quality periodontal care. This trend is incentivizing research and development in the field, leading to more sophisticated treatment options. In fact, recent data shows a 40% increase in consumer spending on advanced dental treatments in Vietnam, reflecting the growing demand and willingness to invest in quality periodontal care.

Advancements in Treatment Technologies: Precision medicine in periodontal care is made possible by advancements in dental technology. Subtle structural variances can be revealed by advanced imaging, opening the door to customized treatment plans. Preventive strategies are informed by the identification of periodontal disease predispositions by genetic testing. Software for designing digital smiles customizes the visual appearance of each unique facial feature. Accurate implant placement is ensured by surgical guidance created in 3D.

Market Restraints

Adverse Effects: side effects such as bleeding gums and tooth sensitivity after periodontal procedures contribute to patient concerns and hesitancy towards seeking timely treatment. Fear of potential complications, including infections or allergic reactions to medications, further hinders patient compliance and deters regular dental visits. Limited awareness about preventive dental care exacerbates these challenges, resulting in delayed treatment seeking behaviors and restrained market growth despite increasing healthcare accessibility.

Limited insurance coverage for periodontal treatments: Limited insurance coverage in Vietnam acts as a restraint on the periodontal market by restricting access to essential dental care. Many insurance plans offer minimal coverage for dental procedures, with limited or no reimbursement for periodontal treatments such as gum surgeries, bone grafts, and other specialized interventions. This lack of comprehensive coverage leaves a significant portion of the population unable to afford necessary periodontal care, leading to untreated gum disease and worsening oral health outcomes.

High cost: The market faces challenges due to the costliness of modern dental techniques and surgeries. Limited availability of comprehensive insurance coverage for dental care adds to the burden, making advanced periodontal treatments unaffordable for many. As a result, despite an increasing burden of periodontal disease, access to high-cost treatments remains restricted. In fact, statistics indicate that only 20% of the population in certain regions have access to comprehensive insurance coverage for dental care, highlighting the significant financial barriers that hinder market growth potential.

Regulatory Landscape and Reimbursement scenario

Periodontics market is governed by the Drug Administration of Vietnam (DAV), which oversees regulatory approvals and market access for periodontal treatments and products. DAV mandates stringent requirements for product registration, including clinical trials, safety assessments, and compliance with local standards. Manufacturers and distributors must navigate these regulations to obtain marketing authorizations, ensuring products meet quality and safety benchmarks before entering the market. Regulatory updates and adherence to DAV guidelines are crucial for navigating Vietnam's evolving healthcare landscape in periodontics.

Reimbursement plays a critical role in healthcare access and affordability. The landscape is shaped by a combination of public and private insurance systems, with varying coverage levels and reimbursement mechanisms. Public insurance typically covers a basic range of periodontal treatments, while private insurance offers more comprehensive options depending on plan specifics. Reimbursement rates can impact treatment accessibility and patient choice, influencing the adoption of advanced periodontal procedures and technologies. Regulatory frameworks ensure reimbursement aligns with accepted standards of care, fostering a dynamic market where healthcare providers navigate reimbursement policies to optimize patient outcomes while managing financial viability.

Competitive Landscape

Key Players

Here are some of the major key players in Vietnam Periodontal Therapeutics Market:

• Pfizer Inc.
• Lupin Ltd
• Teva Pharmaceuticals USA, Inc.
• Sun Pharmaceutical Industries Ltd.
• Tokyo Chemical Industry Co., Ltd.
• Bausch Health Companies Inc.
• Melinta Therapeutics LLC
• Cipla, Inc.
• Chartwell Pharmaceuticals LLC.
• ASA Dental S.p.A.
• Steris-Hu-Friedy
• Carl Martin GmBH